ESC 365 - Apolipoprotein C-III Reduction in Cardiovascular Disease

ESC Premium Access

Apolipoprotein C-III Reduction in Cardiovascular Disease

Session: Late-Breaking Science in Lipids

Topic: Drug therapy

Speaker: Doctor J. Tardif (Montreal, CA)

Event: ESC Congress 2020

Congress Presentation

About the speaker

Doctor Jean-Claude Tardif

Montreal Heart Institute, Montreal (Canada)

8 presentations

0 follower

2 more presentations in this session

ANGPTL3 antisense oligonucleotide to lower triglycerides

Speaker: Doctor D. Gaudet (Montreal, CA)

Final Results of the EVAPORATE Trial

Speaker: Doctor M. Budoff (Torrance, US)

Access the full session

Late-Breaking Science in Lipids

Speakers: Doctor J. Tardif, Doctor D. Gaudet, Doctor M. Budoff

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by